Dare Bioscience, Inc. is an intention-driven, accelerated biotech company completely targeting covering the gap between real-world solutions and promising science to improve women’s health will be on stage in a live webinar for the DARE to PLAY™ DIFFERENCE following its commercial launch.
The live webinar will be enlightened with popular menopause and sexual health clinicians, Dr Jim Simon and Dr Sheryl Kingsberg, on 17th November 2025 on Monday. The title ‘The DARE to PLAY™ Difference’ will attract the attention of many healthcare leaders and individuals seeking such a cure.
The cream is the first of the spectacular topical sildenafil formulation engineered particularly for women to improve arousal response and genital blood flow. Well backed by the clinical data elaborated rise of genital blood flow in 10 to 15 minutes of application and enhancement in arousal sensations based on clinical proven and FDA green signal endpoints to DARE to PLAY™. This cream is the first ever and one of the evidence harnessed sildenafil cream formulations for the female population.
The on-the-way commercial access via a 503B outsourcing facility will leave the footprint of being one of the first topical sildenafil formulations manufactured, considering cGMP requirements and backed by clinical data as an important factor to be reached by healthcare professionals and their patient group.
The webinar has prioritised the participants by giving them an opportunity to be a part of the product alert list, to make sure they get to know DARE to PLAY™ Sildenafil Cream’s availability date (on prescription). The webinar is open for discussion for investors, women searching for a valuable science-driven idea to enhance sexual response and clinicians.
The webinar will be science-driven, along with leading Dr Jim Simon and Dr Sheryl Kingsberg from different clinical settings and areas of expertise, holding past presidents of the International Society of the Study of Women’s Sexual Health (ISSWSH) and Menopause Society. Whereas, Dr Sheryl Kingsberg is the professor in Reproductive Biology, Psychiatry and Urology at Case Western Reserve University and Division Chief of Behavioral Medicine at University Hospitals MacDonald Women’s Hospital.
These experts have specialised in many women's sexual health-related conditions, covering psychological aspects of infertility, menopause, pregnancy, postpartum mood disorders, and sexual disorders, mainly by Dr James Simon. Dare Bioscience's efforts and promotion skills are highly commendable and valued.
Mansi Kadam is a market research writer with over 3 years of experience analyzing trends in the healthcare industry. At Towards Healthcare, she covers innovations in medical sector, sustainability initiatives, and the evolving regulatory landscape.
